Search research articles
Contact Us
Filters
Showing results (1261-1270 of 1,352) with videos related to
Page
of 136
Sort By:
The New England Journal of Medicine
|
September 8, 2021
Benefits and Risks of Iron Interventions in Infants in Rural Bangladesh
Sant-Rayn Pasricha, M Imrul Hasan, Sabine Braat, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology
|
April 29, 2026
Considerations for early life genetic therapies in cystic fibrosis
Ashley L Cooney, Ian M Thornell, Alejandro A Pezzulo, et al.
The Behavioral and Brain Sciences
|
March 31, 2017
On the neural implausibility of the modular mind: Evidence for distributed construction dissolves boundaries between perception, cognition, and emotion
Leor M Hackel, Grace M Larson, Jeffrey D Bowen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 20, 2005
Progress and promise of FDG-PET imaging for cancer patient management and oncologic drug development
Gary J Kelloff, John M Hoffman, Bruce Johnson, et al.
The Journal of Clinical Investigation
|
September 27, 2016
Sustained ERK inhibition maximizes responses of BrafV600E thyroid cancers to radioiodine
James Nagarajah, Mina Le, Jeffrey A Knauf, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 14, 2019
Biodistribution and Dosimetry of Intraventricularly Administered <sup>124</sup>I-Omburtamab in Patients with Metastatic Leptomeningeal Tumors
Neeta Pandit-Taskar, Pat B Zanzonico, Kim Kramer, et al.
Molecular Metabolism
|
March 8, 2021
The melanocortin pathway and energy homeostasis: From discovery to obesity therapy
Giles S H Yeo, Daniela Herrera Moro Chao, Anna-Maria Siegert, et al.
Investigational New Drugs
|
June 4, 2013
Vorinostat and bortezomib as third-line therapy in patients with advanced non-small cell lung cancer: a Wisconsin Oncology Network Phase II study
Tien Hoang, Toby C Campbell, Chong Zhang, et al.
Cancer Research
|
March 20, 2019
An HK2 Antisense Oligonucleotide Induces Synthetic Lethality in HK1<sup>-</sup>HK2<sup>+</sup> Multiple Myeloma
Shili Xu, Tianyuan Zhou, Hanna M Doh, et al.
Neuro-Oncology
|
February 19, 2025
Phase 1 dose-escalation trial using convection-enhanced delivery (CED) of radio-immunotheranostic 124I-Omburtamab for diffuse intrinsic pontine glioma (DIPG)
Mark M Souweidane, Evan D Bander, Pat Zanzonico, et al.
Page
of 136
Search research articles
Search
Showing results (1261-1270 of 1,352) with videos related to
Sort By:
Page
of 136
The New England Journal of Medicine
|
September 8, 2021
Benefits and Risks of Iron Interventions in Infants in Rural Bangladesh
Sant-Rayn Pasricha, M Imrul Hasan, Sabine Braat, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology
|
April 29, 2026
Considerations for early life genetic therapies in cystic fibrosis
Ashley L Cooney, Ian M Thornell, Alejandro A Pezzulo, et al.
The Behavioral and Brain Sciences
|
March 31, 2017
On the neural implausibility of the modular mind: Evidence for distributed construction dissolves boundaries between perception, cognition, and emotion
Leor M Hackel, Grace M Larson, Jeffrey D Bowen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 20, 2005
Progress and promise of FDG-PET imaging for cancer patient management and oncologic drug development
Gary J Kelloff, John M Hoffman, Bruce Johnson, et al.
The Journal of Clinical Investigation
|
September 27, 2016
Sustained ERK inhibition maximizes responses of BrafV600E thyroid cancers to radioiodine
James Nagarajah, Mina Le, Jeffrey A Knauf, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 14, 2019
Biodistribution and Dosimetry of Intraventricularly Administered <sup>124</sup>I-Omburtamab in Patients with Metastatic Leptomeningeal Tumors
Neeta Pandit-Taskar, Pat B Zanzonico, Kim Kramer, et al.
Molecular Metabolism
|
March 8, 2021
The melanocortin pathway and energy homeostasis: From discovery to obesity therapy
Giles S H Yeo, Daniela Herrera Moro Chao, Anna-Maria Siegert, et al.
Investigational New Drugs
|
June 4, 2013
Vorinostat and bortezomib as third-line therapy in patients with advanced non-small cell lung cancer: a Wisconsin Oncology Network Phase II study
Tien Hoang, Toby C Campbell, Chong Zhang, et al.
Cancer Research
|
March 20, 2019
An HK2 Antisense Oligonucleotide Induces Synthetic Lethality in HK1<sup>-</sup>HK2<sup>+</sup> Multiple Myeloma
Shili Xu, Tianyuan Zhou, Hanna M Doh, et al.
Neuro-Oncology
|
February 19, 2025
Phase 1 dose-escalation trial using convection-enhanced delivery (CED) of radio-immunotheranostic 124I-Omburtamab for diffuse intrinsic pontine glioma (DIPG)
Mark M Souweidane, Evan D Bander, Pat Zanzonico, et al.
Page
of 136